Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Tummy Troubles -- Gastrin Key In Bacterial-Induced Stomach Cancer
Current research suggests that levels of gastrin play a key role in the development of Helicobacter-induced stomach cancer. The related report by Takaishi et al, "Gastrin is an essential cofactor for Helicobacter-associated gastric corpus carcinogenesis in C57BL/6 mice," appears in the July 2009 issue of The American Journal of Pathology.

ATS Medical Announces FDA Clearance And First Implant Of New ATS Simulus Semi-Rigid Annuloplasty Band
ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced FDA clearance and the first implant of the ATS Simulus(R) Semi-Rigid Annuloplasty Band. The Simulus Semi-Rigid Annuloplasty Band was developed through the Company"s collaboration with Genesee BioMedical and represents the latest addition to the expanding portfolio of valve repair products.
News of the day
Actuaries Weigh In On Ways To Address Risk Exposures And Challenges With The U.S. Health Care System
Many interested parties and organizations have provided recommendations on U.S. health care reform, but there is much to be done in terms of mapping out its future. As leading health care professionals, actuaries are looked to for their points of view on this important topic. Providing new health insights, the Society of Actuaries" Health Section has published a collection of 29 essays from actuaries, health care professionals and academics titled, "Visions for the Future of the U.S. Health Care System." The essays cover a wide array of health care issues, but there are four underlying angles: general reform and restructuring of the health care system; risk pooling and risk-adjusted payments; evidence-based medicine and more efficient cost/care.
Public Health

New Code Of Ethics For More Transparent Medical Technology Industry

RAJ Devices, the regulatory affairs journal published by Informa and covering the medical technology industry, has published a comprehensive feature on how companies in the US can comply with a much stricter code of ethics that medical technology industry association AdvaMed will launch on 1 July. AdvaMed, which represents medical technology companies that produce 90% of devices and diagnostics sold in the US and 50% of those sold worldwide, is also encouraging companies that are not members to adopt its new code. "The revised code contains completely new guidance in a number of areas," says Andrew Van Haute,associate general counsel at AdvaMed. The new rules cover, among other things, the payment of royalties to healthcare professionals who help develop medical technology; the provision of demonstration and evaluation products; and the complete prohibition on gifts, entertainment and recreation. In addition, the code provides strong encouragement and incentives to companies who certify that they will comply. Medical technology companies and the healthcare profession are entering a new era in terms of how they deal with each other. Federal and state legislatures in the US are considering or have already passed disclosure laws affecting companies and healthcare professionals. Efforts to improve transparency outside the US are also under way by industry bodies. Medical professionals often work in tandem with companies to invent and improve upon medical devices, Mr Van Haute explains. Both parties also collaborate to design effective clinical trials of devices and once a product is in the field, companies work closely with healthcare professionals to ensure the product is used properly. While these interactions are clearly necessary and vital, they occasionally present the potential for conflicts of interest in that healthcare professionals might base clinical decisions on their relationship with a company rather than on the best interests of their patients. As such, the relationships between physicians and industry have come under the scrutiny of lawmakers, prosecutors and the public. For many years, AdvaMed has made available a code of ethics to help industry ensure that all decisions made by healthcare professionals were based on the best interests of their individual patients and not on their relationship with a medical technology company. However, with the revised code, AdvaMed is helping to extend patient protection with greater transparency and clear demarcations for industry relationships. "The new code spells out the rules in very certain terms," says Neena Brizmohun, Deputy Editor of RAJ Devices. "Training, educational conferences, entertainment, gifts, consulting arrangements, meals, royalty payments, grants and donations, and overall code compliance are all covered in detail." RAJ Devices


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009